CYNTHIA OWUSU, MD, MSc.
Curriculum Vitae

EDUCATION:

1985-1988 University of Science and Technology Kumasi, Ghana
B.Sc. Human Biology

1988-1991 University of Science and Technology Kumasi, Ghana
M.B., Ch.B.

2002-2006 Boston University School of Public Health Boston, MA
M.Sc. Epidemiology

TRAINING:
1999-2002 Beth Israel Medical Center Newark, New Jersey
Intern/Resident: Department of Medicine

2002-2006 Boston University Medical Center Boston, MA
Clinical and Research Fellow: Departments of
Geriatrics/Hematology-Oncology


PROFESSIONAL APPOINTMENTS:


1993-1998 Komfo Anokye Teaching Hospital Kumasi, Ghana
Medical Officer: Department of Medicine


2006-Present Case Western Reserve University Cleveland, OH
Assistant Professor of Medicine
Director, Senior Adult Oncology Program
Division of Hematology/Oncology

2006-Present Associate Medical Director, Hospice Cleveland, OH
and Palliative Care Partners of Ohio

LICENSURE AND BOARD CERTIFICATION:

2002 Massachusetts #212474
2006 Ohio #087453

Board Certified
2002-2012 Internal Medicine
2006-2016 Medical Oncology
2007-2017 Geriatrics

Board Eligible
2006 Hematology


PROFESSIONAL ORGANIZATIONS:

2002-Present American Society of Clinical Oncology
2005-Present Society of International Geriatric Oncology
2007-Present American Geriatrics Society


PUBLICATIONS:

A. Manuscripts

1. Owusu C, Buist D, Field T, et al: Predictors of Tamoxifen Discontinuation among Older Women with Estrogen Receptor Positive Breast Cancer. J Clin Oncol. 2008 Feb 1;26(4):549-55.
2. Buist DSM, Ichikawa L, Prout M, Ulcickas Yood M, Field T, Owusu C, et al. Receipt of primary breast cancer therapy and adjuvant therapy are not associated with obesity in older women with access to health care. JCO Aug 10 2007: 3428-3436.

3. Owusu C, Lash TL, Silliman RA: Effectiveness of Adjuvant Tamoxifen Therapy among Older Women with Early Stage Breast Cancer. Breast J 13:374-82, 2007

4. Owusu C, Lash TL, Silliman RA: Effect of undertreatment on the disparity in age-related breast cancer-specific survival. Breast Cancer Res Treat 102:227-36, 2007

5. Ulcickas Yood M, Owusu C, Buist DSM, et al: The Mortality Impact of Less Than Standard Therapy in Older Breast Cancer Patients. Journal of the American College of Surgeons. (In press)


B. Abstracts


1. Siran K, Owusu C, Madigan E, et al: Clinical Presentation, Sensory Impairment, Social Support, and Cancer Stage in Elders with Cancer. 2007 Annual meeting of the Gerontological Society of America

2. Owusu C, Buist D, Field T, et al: Tamoxifen Discontinuance among Older women with Estrogen-receptor-positive Breast Cancer. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 648

3. Owusu O, Owusu C, Hankins M: The Effect of Age on Treatment and Survival among Patients with Non Small Cell Lung Cancer. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 18504

4. Owusu C, Lash TL, Silliman RA: The Effectiveness of Adjuvant Tamoxifen in Older Women with Early Stage Breast Cancer. Abstract, 6th Meeting of the International Society of Geriatric Oncology, Geneva, Switzerland, Sep 2005


GRANT AWARDS:

Current Grant Awards

2006 Recipient of a K12 (CA076917-10) Clinical Oncology Research Career
Development Program
“Safety and efficacy of Single agent Trastuzumab in Older women with Early-
stage Breast Cancer: A Phase II Trial”.
Role: PI
Amount - $150,000.00; Duration- 2 years; % effort – 75%

2007 Cancer Research Program at the Case Comprehensive Cancer Center P20
103736
“A Randomized Controlled Trial of Outpatient Geriatric Evaluation and
Management among Older Women with Early-stage Breast and Colon Cancer”
Role: PI
Amount - $100,000.00; Duration- 2 years;

Past Grant Awards

2005 Recipient of ASCO foundation Young Investigator Award
“Racial Disparities among Older Breast Cancer Patients”.
Role: PI
Amount - $35,000.00; Duration- 1 year; % effort – 40%

2005 Recipient of NIH Minority Supplement Grant
Supplement to R01 CA093772, “Breast Cancer Treatment
Effectiveness in Older Women”.
Role: Data analysis and manuscript preparation
Amount - $59,677.00; Duration- 1 year; % effort – 35%


Collaborative Research

2007 Case Comprehensive Center intramural funding
“Predicting use of Home Health Care, Long-term Care, and Hospice by Elders
with Cancer: A Nuanced Approach to Risk Adjustment”
Role: Co-Investigator
Amount - $50,000.00; Duration- 1 year

2007 NIA/NIH Paul Beeson’s Career Development Award:
Recipient and PI: Arti Hurria, MD, City of Hope
“Determining the Utility of an Assessment Tool for Older Patients with Cancer”
Role: Co-investigator

 

 

© 2007 The Helen Moss Breast Cancer Research Foundation
a 501(c)(3) public foundation
9619 Lake Shore Blvd., Bratenahl, OH 44108
website by Shanessa.com